William Scott Durall - 22 Jul 2025 Form 4 Insider Report for CARLSMED, INC.

Reporting relationship: Chief Commercial Officer
Issuer ticker: CARL on Nasdaq
Reported as of: 22 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Jul 2025, 20:34:46 UTC
Prior SEC filing: 08 May 2023
Next SEC filing: 30 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Leonard Greenstein, as attorney-in-fact, for William Scott Durall

Key filing fact

William Scott Durall filed Form 4 for CARLSMED, INC. on 24 Jul 2025.

Key facts

This page summarizes William Scott Durall's Form 4 filing for CARLSMED, INC..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 Jul 2025, 20:34.

Change

Previous filing in this sequence was filed on 08 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001818744 Primary reporting owner

Durall William Scott

Relationship: Chief Commercial Officer
Address: C/O CARLSMED, INC., 1800 ASTON AVE., SUITE 100, CARLSBAD
Signature: /s/ Leonard Greenstein, as attorney-in-fact, for William Scott Durall
Signature date: 24 Jul 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CARL transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value: $0
Shares: +71,429
Change %: +32%
Price: $0.000000
Shares after: 296,008
Date: 22 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 71,429
Exercise price: $15.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The unvested stock options are convertible into approximately 71,429 shares of the Issuer's common stock and will begin to vest in equal installments on each quarterly anniversary of July 22, 2025 (the "Grant Date"), such that all of the stock options will be vested on the fourth anniversary of the Grant Date, provided that the Reporting Person remains in continuous service through each applicable vesting date.